Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
596,465,578
-
Share change
-
-9,709,277
-
Total reported value
-
$31,927,539,469
-
Put/Call ratio
-
66%
-
Price per share
-
$53.51
-
Number of holders
-
825
-
Value change
-
-$699,029,161
-
Number of buys
-
358
-
Number of sells
-
406
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q1 2016
As of 31 Mar 2016,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
825 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
596,465,578 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, Viking Global Investors LP, PAULSON & CO. INC., Invesco Ltd., WADDELL & REED FINANCIAL INC, LAZARD ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, NORGES BANK, and Capital Research Global Investors.
This page lists
827
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.